538 related articles for article (PubMed ID: 29373046)
1. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals.
Ferreira CL; Lamsa E; Woods M; Duan Y; Fernando P; Bensimon C; Kordos M; Guenther K; Jurek P; Kiefer GE
Bioconjug Chem; 2010 Mar; 21(3):531-6. PubMed ID: 20175523
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of macrocyclic amino acid derivatives for tumor imaging by gallium-68 positron emission tomography.
Shetty D; Jeong JM; Ju CH; Kim YJ; Lee JY; Lee YS; Lee DS; Chung JK; Lee MC
Bioorg Med Chem; 2010 Nov; 18(21):7338-47. PubMed ID: 20926300
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.
Ray Banerjee S; Chen Z; Pullambhatla M; Lisok A; Chen J; Mease RC; Pomper MG
Bioconjug Chem; 2016 Jun; 27(6):1447-55. PubMed ID: 27076393
[TBL] [Abstract][Full Text] [Related]
6. Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators.
Chakravarty R; Chakraborty S; Dash A; Pillai MR
Nucl Med Biol; 2013 Feb; 40(2):197-205. PubMed ID: 23218795
[TBL] [Abstract][Full Text] [Related]
7.
Jain A; Mathur A; Pandey U; Sarma HD; Dash A
Bioorg Med Chem Lett; 2016 Dec; 26(23):5785-5791. PubMed ID: 27793567
[TBL] [Abstract][Full Text] [Related]
8. Radiosynthesis and bioevaluation of [68Ga]-labeled 5,10,15,20-tetra(4-methylpyridyl)-porphyrin for possible application as a PET radiotracer for tumor imaging.
Bhadwal M; Das T; Dev Sarma H; Banerjee S
Mol Imaging Biol; 2015 Feb; 17(1):111-8. PubMed ID: 25037973
[TBL] [Abstract][Full Text] [Related]
9. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
[TBL] [Abstract][Full Text] [Related]
10. Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN
Cheng S; Lang L; Wang Z; Jacobson O; Yung B; Zhu G; Gu D; Ma Y; Zhu X; Niu G; Chen X
Bioconjug Chem; 2018 Feb; 29(2):410-419. PubMed ID: 29254329
[TBL] [Abstract][Full Text] [Related]
11. (68)Ga/DOTA- and (64)Cu/NOTA-phthalocyanine conjugates as fluorescent/PET bimodal imaging probes.
Ranyuk E; Lebel R; Bérubé-Lauzière Y; Klarskov K; Lecomte R; van Lier JE; Guérin B
Bioconjug Chem; 2013 Sep; 24(9):1624-33. PubMed ID: 23978056
[TBL] [Abstract][Full Text] [Related]
12. A novel 177Lu-labeled porphyrin for possible use in targeted tumor therapy.
Das T; Chakraborty S; Sarma HD; Banerjee S; Venakatesh M
Nucl Med Biol; 2010 Jul; 37(5):655-63. PubMed ID: 20610170
[TBL] [Abstract][Full Text] [Related]
13. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.
Roosenburg S; Laverman P; Joosten L; Cooper MS; Kolenc-Peitl PK; Foster JM; Hudson C; Leyton J; Burnet J; Oyen WJ; Blower PJ; Mather SJ; Boerman OC; Sosabowski JK
Mol Pharm; 2014 Nov; 11(11):3930-7. PubMed ID: 24992368
[TBL] [Abstract][Full Text] [Related]
14. H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.
Bailey GA; Price EW; Zeglis BM; Ferreira CL; Boros E; Lacasse MJ; Patrick BO; Lewis JS; Adam MJ; Orvig C
Inorg Chem; 2012 Nov; 51(22):12575-89. PubMed ID: 23106422
[TBL] [Abstract][Full Text] [Related]
15. Design of Ga-DOTA-based bifunctional radiopharmaceuticals: two functional moieties can be conjugated to radiogallium-DOTA without reducing the complex stability.
Mukai T; Suwada J; Sano K; Okada M; Yamamoto F; Maeda M
Bioorg Med Chem; 2009 Jul; 17(13):4285-9. PubMed ID: 19481944
[TBL] [Abstract][Full Text] [Related]
16. Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study.
Guleria M; Das T; Kumar C; Sharma R; Amirdhanayagam J; Sarma HD; Dash A
Anticancer Agents Med Chem; 2018; 18(1):146-153. PubMed ID: 28745238
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of a radiogallium-labeled bifunctional radiopharmaceutical, Ga-DOTA-MN2, for hypoxic tumor imaging.
Sano K; Okada M; Hisada H; Shimokawa K; Saji H; Maeda M; Mukai T
Biol Pharm Bull; 2013; 36(4):602-8. PubMed ID: 23546294
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of
Xia Y; Zeng C; Zhao Y; Zhang X; Li Z; Chen Y
EJNMMI Res; 2020 Apr; 10(1):36. PubMed ID: 32297029
[TBL] [Abstract][Full Text] [Related]
19. Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics.
Kumar P; Tripathi SK; Chen CP; Wickstrom E; Thakur ML
Mol Imaging Biol; 2019 Feb; 21(1):130-139. PubMed ID: 29802552
[TBL] [Abstract][Full Text] [Related]
20. Studies on efficacy of a novel 177Lu-labeled porphyrin derivative in regression of tumors in mouse model.
Sarma HD; Das T; Banerjee S; Venkatesh M; Vidyasagar PB; Mishra KP
Curr Radiopharm; 2011 Apr; 4(2):150-60. PubMed ID: 22191655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
